SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-009802
Filing Date
2016-05-09
Accepted
2016-05-09 08:16:05
Documents
48
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050916p.htm 10-Q 690112
2 EXHIBIT 10.1 exh_101.htm EX-10.1 21295
3 EXHIBIT 31.1 exh_311.htm EX-31.1 7888
4 EXHIBIT 31.2 exh_312.htm EX-31.2 6147
5 EXHIBIT 32.1 exh_321.htm EX-32.1 4904
12 GRAPHIC lonza.jpg GRAPHIC 24532
  Complete submission text file 0001171843-16-009802.txt   2469968

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prto-20160331.xml EX-101.INS 304307
7 XBRL SCHEMA FILE prto-20160331.xsd EX-101.SCH 28349
8 XBRL CALCULATION FILE prto-20160331_cal.xml EX-101.CAL 25926
9 XBRL DEFINITION FILE prto-20160331_def.xml EX-101.DEF 181065
10 XBRL LABEL FILE prto-20160331_lab.xml EX-101.LAB 178873
11 XBRL PRESENTATION FILE prto-20160331_pre.xml EX-101.PRE 197407
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 161629971
SIC: 2836 Biological Products, (No Diagnostic Substances)